Quality main issue in prescribing generic drugs: CII president

Image
Press Trust of India New Delhi
Last Updated : May 10 2017 | 6:42 PM IST
Sounding a note of caution on the MCI move asking doctors to prescribe only generic medicines, CII President Shobana Kamineni has said poor quality of drugs could be dangerous for patients.
Kamineni, who is also Executive Vice Chairperson of Apollo Hospitals Enterprises, pitched for making India a major medical tourism destination to "heal the world".
During an interaction with PTI, she also made a strong case for promoting traditional medicines like Ayurveda.
On the contentious issue of doctors being asked to prescribe generic medicines instead patented drugs, Kamineni said the real problem is quality of drugs.
"If the generics are high quality, yes. Quality is the main thing. You cannot inject something that is not good quality... People can take the wrong thing. That's also a danger," said the first woman president of the leading industry chamber.
She said that for pharmacist, who are only diploma holders, it would not be easy to interpret the right mixture of salts and molecules of a generic drugs.
"It's important that a via media is found... If we need to create more access to health care, let us find the way. But let us find the safe way," she added.
Observing the cost of health care is low in India in comparison to developed world, the CII president said the country has an unique opportunity to become hub of medical tourism.
The Medical Council of India (MCI) has advised doctors to prescribe medicines by generic names in place of brand names.
While generics have established bioequivalence with the originators' products, similars have not.
The Indian Pharmaceutical Alliance (IPA) patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines.
Kamineni, whose group firm Apollo Pharmacy is among the biggest organised chemists in the country, said alopathy doctors are not allowed to prescribe Ayurvedic medicines.
"We have science in Ayurveda. We have science in Yoga and we should celebrate that," she said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 10 2017 | 6:42 PM IST

Next Story